Medical research, risk, and bystanders

IRB Ethics and Human Research

Volumn 27, Issue 4, 2005, Pages 1-6

  Kimmelman, Jonathan ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 27944493654     PISSN: 01937758     EISSN: None     Source Type: Journal    
DOI: 10.2307/3563953     Document Type: Article

References (37)

1. World Medical Association. http://www.wma.net/e/policy/b3.htm.
2. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington, DC: Government Printing Office, 1979.
3. Yoon CK. Families emerge as silent victims of Tuskegee syphilis experiments. In: Reverby SM. Tuskegee's Truths: Rethinking the Tuskegee Syphilis Study. Chapel Hill: University of North Carolina Press, 2000, p. 457-462.
4. Singh AE, Romanowski B. Syphilis: Review with emphasis on clinical, epidemiologic, and some biologic features. Clinical Microbiology Reviews 1999;12:187-209.
5. Benedek T. The "Tuskegee Study" of syphilis: Analysis of moral versus methodologic aspects. In: Reverby SM. Tuskegee's Truths: Rethinking the Tuskegee Syphilis Study. Chapel Hill: University of North Carolina Press, 2000, p. 213-235.
6. Weiss RA. Xenotransplantation. BMJ 1998;317:931-934.
7. See ref. 6, Weiss 1998.
8. Kirn D, Martuza RL, Zwiebel J. Replication-selective virotherapy for cancer: Biological principles, risk management and future directions. Nature Medicine 2001;7:781-787.
9. Buchschacher GL Jr., Wong-Staal F. Development of lentiviral vectors for gene therapy for human diseases. Blood 2000;95:2499-2504.
10. Grady C, Miller FG. The ethical challenge of infection-inducing challenge experiments. Clinical Infectious Diseases 2001; 33:1028-1033.
11. Hoshino Y, Wagner M, Yan XY, et al. Horizontal transmission of rhesus monkey rotavirus-based quadrivalent vaccine during a phase 3 clinical trial in Caracas, Venezuala. Journal of Infectious Diseases 2003;187:791-800.
12. LaRussa P, Steinberg S, Meurice F, et al. Transmission of vaccine strain varicella-zoster virus from a healthy adult with vaccine-associated rash to susceptible household contacts. Journal of Infectious Diseases 1997; 176:1072-1075.
13. Gershon AA, Steinberg SP, Gelb L, et al. JAMA 1984;252:355-362.
14. Whitney JB, Ruprecht RM. Live attenuated HIV vaccines: Pitfalls and prospects. Current Opinion in Infectious Diseases 2004; 17:17-26.
15. Grigsby PW, Siegel BA, Baker S, et al. Radiation exposure from outpatient radioactive iodine (131I) therapy for thyroid carcinoma. JAMA 2000;283:2272-2274;
16. Mountford PJ. Risk assessment of the nuclear medicine patient. British Journal of Radiology 1997; 70:671-684.
17. Barrington SF, O'Doherty MJ, Kettle AG, et al. Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism. European Journal of Nuclear Medicine 1999;26:686-692.
18. Martenyi F, Brown EB, Zhang H, et al. Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder. British Journal of Psychiatry 2002;181:315-320;
19. Hollander E, Tracy KA, Swann AC, et al. Divalproex in the treatment of impulsive aggression: Efficacy in cluster B personality disorders. Neuropyschopharmacology 2003;28:1186-1197.
20. Weijer C. Protecting communities in research: Philosophical and pragmatic challenges. Cambridge Quarterly of Healthcare Ethics 1999;8:501-513.
21. Botkin JR. Protecting the privacy of family members in survey and pedigree research. JAMA 2001;285:207-211.
22. Beskow LM, Botkin JR, Daly M, et al. Ethical issues in identifying and recruiting participants for familial genetic research. American Journal of Medical Genetics 2004;130A:424-431.
23. Schillinger JA, Kissinger P. Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: A randomized, controlled trial. Sexually Transmitted Diseases 2000;30:49-56.
24. Shapiro SH, Ernst P, Gray-Donald K, et al. Effect of negative pressure ventilation in severe chronic obstructive pulmonary disease. Lancet 1992;340:1425-1429.
25. Food and Drug Administration. Availability for public disclosure and submission to FDA for public disclosure of certain data and information related to human gene therapy or xenotransplantaton. Federal Register 2001 (January 18); 66,12:4688-4706.
26. Department of Health and Human Services. PHS Guideline on Infectious Disease Issues in Xenotransplantation. U.S. Public Health Service. January 19, 2001.
27. Annas GJ. Reforming informed consent to genetic research. JAMA 2001; 286:2326-2328;
28. Foster M, Bernsten D, Carter T. A model agreement for genetic research in socially identifiable populations. American Journal of Human Genetics 1998;63:696-702; see ref. 18, Weijer 1999.
29. Levine RJ. Ethics and Regulation of Clinical Research. 2nd ed. New Haven, CT: Yale University Press, 1986.
30. Enserink M. Activist throws a bright light on institutions' biosafety panels. Science 2004;305:768-769.
31. Light DW, McGee G. On the social embeddedness of bioethics. In: De Vries R. Bioethics and Society. New York: Prentice Hall, 1998, p. 1-15;
32. Wolpe PR. The triumph of autonomy in American bioethics: A sociological view. In: De Vries R. Bioethics and Society. New York: Prentice Hall, 1998, p. 38-59.
33. Christakis NA. Social networks and collateral health effects. BMJ 2004;329:184-185.
34. Wilkinson TH. Individualism and the ethics of research on humans. HEC Forum 2004;16:6-26.
35. Beskow LM, Burke W, Merz JF, et al. Informed consent for population-based research involving genetics. JAMA 2001;286:2315-2321.
36. Wood A, Grady C, Emanuel EJ. Regional ethics organizations for protection of human research participants. Nature Medicine 2004;10:1283-1288.
37. Reilly PR. Rethinking risks to human subjects in genetic research. American Journal of Human Genetics 1998;63:682-685.